Journals / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 5

Survival Benefit with Gross Total Resection and Adjuvant Radiotherapy in Childhood Atypical Teratoid/Rhabdoid Tumors: Results of a Single-Center Cohort of 27 Cases

Pages
689–697
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

AIM: To share a single center experience with 27 atypical teratoid/rhabdoid tumor (AT/RT) cases, and to determine the effect ofgross total tumor resection and other clinical characteristics on the overall survival rate of AT/RT.MATERIAL and METHODS: We included 27 patients—with a histopathologically confirmed primary intracranial childhood AT/RT—who were operated in our clinic between January 2000 and December 2017.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To share a single center experience with 27 atypical teratoid/rhabdoid tumor (AT/RT) cases, and to determine the effect ofgross total tumor resection and other clinical characteristics on the overall survival rate of AT/RT.MATERIAL and METHODS: We included 27 patients—with a histopathologically confirmed primary intracranial childhood AT/RT—who were operated in our clinic between January 2000 and December 2017.
📊
Key Findings & Data:Age, sex, tumor location, disseminated disease,the presence of hydrocephalus, symptom duration till diagnosis, the extent of resection, and adjuvant radiotherapy were evaluatedfor their influence on overall survival.RESULTS: Median age at diagnosis for 27 patients was 19.1 months (7.2 months-5 years).
💡
Conclusion & Impact:Radiotherapyseems to prolong survival; however, large-scale studies are needed to establish prognostic factors.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To share a single center experience with 27 atypical teratoid/rhabdoid tumor (AT/RT) cases, and to determine the effect ofgross total tumor resection and other clinical characteristics on the overall survival rate of AT/RT.MATERIAL and METHODS: We included 27 patients—with a histopathologically confirmed primary intracranial childhood AT/RT—who were operated in our clinic between January 2000 and December 2017. Age, sex, tumor location, disseminated disease,the presence of hydrocephalus, symptom duration till diagnosis, the extent of resection, and adjuvant radiotherapy were evaluatedfor their influence on overall survival.RESULTS: Median age at diagnosis for 27 patients was 19.1 months (7.2 months-5 years). Gross total resection was possible in 13(48.72%) patients. Except for three patients who died of perioperative complications, all patients received chemotherapy and 11received radiotherapy. In univariate analysis, male sex, older age at diagnosis (≥24 months), gross total resection, and radiotherapywere associated with overall longer survival; however, radiotherapy remained the only significant parameter in multivariate analysis.CONCLUSION: AT/RT is a rare and dreadful brain tumor that has low survival rates despite contemporary treatment. Radiotherapyseems to prolong survival; however, large-scale studies are needed to establish prognostic factors.

🔖

Cite This Article

IŞIKAY, İ., HANALIOGLU, S., BASAR, I., NARİN, F., BİLGİNER, B. (2019). Survival Benefit with Gross Total Resection and Adjuvant Radiotherapy in Childhood Atypical Teratoid/Rhabdoid Tumors: Results of a Single-Center Cohort of 27 Cases. Turkish Neurosurgery, Cilt: 29 - Sayı: 5, 689–697. https://ajindex.com/articles/404403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Al-Hussaini M, Swaidan M, Al-Jumaily U, Musharbash A: Central nervous system tumors in the first year of life: A clinical and pathologic experience from a single cancer center. Childs Nerv Syst 29:1883-1891, 2013 2. Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Durken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Fruhwald MC: Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007. Cancer Med 5:1765-1775, 2016 3. Biegel JA, Fogelgren B, Zhou JY, James CD, Janss AJ, Allen JC, Zagzag D, Raffel C, Rorke LB: Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 6:2759-2763, 2000 4. Biswas A, Julka PK, Bakhshi S, Suri A, Rath GK: Intracranial atypical teratoid rhabdoid tumor: Current management and a single institute experience of 15 patients from North India. Acta Neurochir (Wien) 157:589-596, 2015 5. Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ: Atypical teratoid/ rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study. Am J Surg Pathol 22:1083-1092, 1998 6. Buscariollo DL, Park HS, Roberts KB, Yu JB: Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 118(17):4212-4219, 2012 7. Chen YW, Wong TT, Ho DM, Huang PI, Chang KP, Shiau CY, Yen SH: Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64:1038-1043, 2006 8. Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW: Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385-389, 2009 9. Dang T, Vassilyadi M, Michaud J, Jimenez C, Ventureyra EC: Atypical teratoid/rhabdoid tumors. Childs Nerv Syst 19:244- 248, 2003 10. Dufour C, Beaugrand A, Le Deley MC, Bourdeaut F, Andre N, Leblond P, Bertozzi AI, Frappaz D, Rialland X, Fou